More electrodes and thinner electrodes were always goals at Medtronic. But neuro device makers across the industry have faced the difficulties of developing chronic implants for stimulation, as well as designing interconnects to bridge the implants with the rest of the physical system.
“I think we’re on a good path to be successful” at Synchron, Banerjee said in an interview with Medical Design & Outsourcing in 2023 before she was promoted to CTO.
Related: Synchron’s plan to beat Neuralink in the neuroprosthetic BCI race